Skip to content

Application of autogenous concentrated growth factor in wound repair of elderly refractory bedsore

Application of autogenous concentrated growth factor in wound repair of elderly refractory bedsore

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121029
Enrollment
Unknown
Registered
2026-03-24
Start date
2023-01-06
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly refractory bedsores

Interventions

Experimental group :The method of applying its gel and liquid CGF to the soft tissue wound of refractory bedsore wounds to repair the wound defect, induce growth, accelerate the healing of local wound
Control group:Traditional wound dressing change

Sponsors

Second People's Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=60 years old, gender not limited, meeting the criteria for defining elderly patients; 2. Meeting the diagnostic criteria for refractory pressure ulcers, that is, having received traditional dressing change treatment for more than one month, the wound has not healed, and there is rotten tissue or inflammatory granulation tissue on the wound. 3. Clear consciousness, basically normal cognitive function, and able to cooperate in completing wound care, treatment and follow-up work; 4. No serious blood system diseases, immune system diseases, malignant tumors, schizophrenia or other serious diseases; 5. Voluntarily participate in this study. Patients or their families are willing to cooperate with the treatment and sign a written informed consent form, and are willing to cooperate with the researchers to complete all research operations, data collection and full follow-up.

Exclusion criteria

Exclusion criteria: 1. Age under 60 years old, not meeting the criteria for defining elderly patients; 2. There are sinus tracts or latent wounds on the surface of pressure sores, making local application of CGF and wound assessment impossible. 3. Suffering from severe hematological diseases, immune system diseases, malignant tumors, cachexia and end-stage diseases, and unable to tolerate research and treatment; 4. Allergic to blood products, or having contraindications for the preparation and application of CGF; 5. Currently undergoing other special treatments that may affect wound healing (such as immunosuppressants, special wound repair drugs, etc.) and unable to suspend them during the study period; 6. Subjects who are unwilling to sign the informed consent form, or who may withdraw from the study halfway, or who are unable to cooperate to complete the entire research operation and follow-up.

Design outcomes

Primary

MeasureTime frame
Wound healing rate;

Secondary

MeasureTime frame
blood glucose;blood pressure;Nutrition status;

Countries

China

Contacts

Public ContactBao Qinwen

Department of Geriatrics, Second People's Hospital of Lianyungang City, Affiliated to Kangda College, Nanjing Medical University

870296906@qq.com+86 133 8295 0011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026